Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trevi Therapeutics, Inc.

6.91
+0.60009.51%
Volume:1.58M
Turnover:10.59M
Market Cap:668.07M
PE:-14.71
High:7.02
Open:6.25
Low:6.14
Close:6.31
Loading ...
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 14, 2023

Major Issues Report

8-K - Current report
Apr 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals